Reveal LINQ Insertable Cardiac Monitor vs FibriCheck

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Reveal LINQ Insertable Cardiac Monitor

by Medtronic

FibriCheck

by FibriCheck

AI Verdict

Both tools leverage AI for cardiac rhythm monitoring and fall under remote patient monitoring. However, the Reveal LINQ is an implantable device offering continuous, long-term ECG monitoring, while FibriCheck is a smartphone application providing on-demand heart rhythm checks via PPG. This distinction makes them suitable for different clinical scenarios, with one focusing on persistent diagnostic insight and the other on patient-initiated, intermittent screening and monitoring.

Choose Reveal LINQ Insertable Cardiac Monitor if…

Choose the Reveal LINQ Insertable Cardiac Monitor if your patient requires continuous, long-term (up to 4.5 years) and highly accurate ECG monitoring for infrequent or asymptomatic arrhythmias, such as unexplained syncope or suspected atrial fibrillation that has been difficult to capture with external devices. This implantable solution is ideal for definitive diagnosis when extended monitoring is critical and patient adherence to external wearables might be a concern.

View Reveal LINQ Insertable Cardiac Monitor →

Choose FibriCheck if…

Choose FibriCheck if your patient needs a convenient, non-invasive solution for regular or on-demand heart rhythm monitoring using their own smartphone, especially for screening or managing known Atrial Fibrillation. This app-based tool provides immediate results and allows for flexible monitoring periods, making it suitable for patients who are comfortable with technology and prefer an accessible, self-managed approach to cardiac care.

View FibriCheck →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Reveal LINQ Insertable Cardiac Monitor	FibriCheck
Pricing	Contact vendor	Subscription-based, with options for monthly or annual payments. prices vary by region and may be partly or fully covered by insurance or employer.
Deployment	Implantable device with data transmitted to a cloud-based platform (CareLink™ network) via patient smartphone app or home communicator.	Cloud-based (private cloud).
BAA Available	Yes AI-estimated	Unknown
FDA Status	Yes AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

FibriCheck

FibriCheck (Tool B) offers superior usability due to its non-invasive nature and direct smartphone camera-based operation, making it immediately accessible and simple for patients to use without a medical procedure. While the Reveal LINQ ICM (Tool A) offers user-friendly data transmission post-implantation via an app or home communicator, the initial surgical requirement presents a significant barrier to general usability.

Clinical Value

Reveal LINQ Insertable Cardiac Monitor

The Reveal LINQ ICM (Tool A) provides continuous, long-term subcutaneous ECG monitoring for up to 4.5 years, offering high-fidelity data for definitive diagnosis of intermittent arrhythmias like AF and syncope. Its AccuRhythm AI specifically reduces false alerts, enhancing diagnostic yield and clinical workflow efficiency. FibriCheck (Tool B) uses smartphone camera-based PPG technology for intermittent heart rhythm measurements, which, while clinically validated for AF detection, is not continuous ECG and relies on patient engagement.

Pricing & Value

FibriCheck

FibriCheck (Tool B) offers significantly better pricing transparency and accessibility with its clear subscription models for both end-users and healthcare providers. The pricing is publicly disclosed, making its value proposition clear. Tool A's pricing is not publicly disclosed and requires direct vendor consultation, indicating a higher cost associated with an implantable medical device and surgical procedure.

Enterprise Readiness

Reveal LINQ Insertable Cardiac Monitor

Medtronic (Tool A), as a leading global medical device company, leverages a robust CareLink network and established infrastructure for seamless integration into complex healthcare systems, including EHR integration and customizable alerts. FibriCheck (Tool B) offers a healthcare professional portal and licensing agreements, demonstrating enterprise capabilities, but Medtronic's long-standing presence and extensive integration with healthcare systems globally provide a more robust and proven enterprise readiness.

Innovation

Reveal LINQ Insertable Cardiac Monitor

While FibriCheck (Tool B) innovates by democratizing heart rhythm monitoring through readily available smartphone technology, Tool A's deep learning AI (AccuRhythm) for reducing false alerts in continuous, high-fidelity ECG data represents a more advanced and clinically impactful innovation. This addresses a complex challenge in long-term data analysis for an implantable device, pushing the boundaries of device intelligence.

Support & Docs

Reveal LINQ Insertable Cardiac Monitor

As a product from Medtronic, a major medical device manufacturer, Tool A is expected to have extensive and robust support, training, and comprehensive documentation for both clinicians and patients, covering technical, clinical, and regulatory aspects. FibriCheck (Tool B) mentions a healthcare professional portal and optional medical expert review, but lacks explicit details on the breadth of its support infrastructure, documentation, or training programs.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Reveal LINQ Insertable Cardiac Monitor	FibriCheck
Name	Reveal LINQ Insertable Cardiac Monitor	FibriCheck
Company	Medtronic	Qompium nv
Key Technology	AccuRhythmu2122 AI algorithms, continuous, long-term subcutaneous ECG monitoring.	Smartphone camera-based PPG technology for heart rhythm measurement, AI-powered algorithm.
Primary Use Case/Detection	Reduce false alerts and enhance diagnostic yield for conditions like atrial fibrillation (AF) and syncope (detection of AF and Pause).	Monitor heart rhythm to detect and monitor arrhythmias, including Atrial Fibrillation (AFib) and other arrhythmias.
Battery Longevity	4.5-year battery longevity (nominal settings)	Not specified
Patient Interface	MyCareLink Heartu2122 mobile app for patient data transmission, MyCareLink Relayu2122 home communicator for data transmission.	Patient-facing mobile application, smartphone camera-based PPG technology.

Videos

Demos, reviews, and walkthroughs featuring Reveal LINQ Insertable Cardiac Monitor and FibriCheck.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for arrhythmia detection and management, considering their different monitoring approaches?

The Reveal LINQ ICM is an implantable device providing continuous, long-term ECG monitoring, best suited for definitive diagnosis of infrequent or serious arrhythmias, with data transmitted to the CareLinku2122 network. FibriCheck is a non-invasive, patient-initiated smartphone app for intermittent heart rhythm monitoring, ideal for screening or follow-up, with results accessible via a healthcare professional portal.

What are the specific clinical advantages of each tool's AI algorithms in terms of diagnostic accuracy and reducing the burden of false positives?

The Reveal LINQ ICM utilizes AccuRhythmu2122 AI algorithms specifically designed to reduce false alerts for Atrial Fibrillation (AF) and Pause events, aiming to enhance diagnostic yield and minimize unnecessary data review over its long monitoring period. FibriCheck's AI-powered algorithm focuses on detecting and analyzing various arrhythmias from smartphone camera-based PPG data, providing immediate and actionable results for patient-initiated measurements, which can aid in screening and monitoring known conditions.

For which specific patient populations or clinical scenarios is each tool most appropriate, considering their different monitoring mechanisms and data output?

The Reveal LINQ ICM is ideal for patients requiring long-term, continuous, high-fidelity ECG monitoring, such as those with unexplained syncope, cryptogenic stroke, or infrequent, highly symptomatic arrhythmias, particularly in cardiology and pediatric settings. FibriCheck is best suited for patients who can actively engage in intermittent self-monitoring, for conditions like paroxysmal AF screening, post-ablation follow-up, or general rhythm monitoring in cardiology, family medicine, and internal medicine practices.

What are the capabilities for integrating the collected data from each tool into a physician's Electronic Health Record (EHR) system for comprehensive patient management?

Data from the Reveal LINQ ICM is transmitted to the Medtronic CareLinku2122 network, which typically offers pathways or portals for clinicians to access and manage patient ECG data, potentially requiring specific interfaces or manual data transfer into the EHR. FibriCheck provides a healthcare professional portal/dashboard for patient monitoring, suggesting capabilities for data export or potential API integrations to facilitate the transfer of rhythm analysis results into an EHR system.

What audit-trail capabilities do these tools offer to track who accessed patient data, when, and what actions were taken, ensuring accountability and compliance?

The CareLinku2122 network for the Reveal LINQ ICM would typically include comprehensive audit logs to track user access, device programming changes, and data review events, which are crucial for regulatory compliance and clinical accountability. FibriCheck's healthcare professional portal would likely feature audit trails to record physician access to patient data, changes to monitoring rules, and review of measurements, ensuring transparency and accountability in patient management.